These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 428024)

  • 1. Bioconversion and biosynthesis of 16-membered macrolide antibiotics. X. Final steps in the biosynthesis of spiramycin, using enzyme inhibitor: cerulenin.
    Omura S; Kitao C; Hamada H; Ikeda H
    Chem Pharm Bull (Tokyo); 1979 Jan; 27(1):176-82. PubMed ID: 428024
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioconversion and biosynthesis of 16-membered macrolide antibiotics. XIII. Regulation of spiramycin I 3-hydroxyl acylase formation by glucose, butyrate, and cerulenin.
    Kitao C; Ikeda H; Hamada H; Omura S
    J Antibiot (Tokyo); 1979 Jun; 32(6):593-9. PubMed ID: 468735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioconversion and biosynthesis of 16-membered macrolide antibiotic, tylosin, using enzyme inhibitor: cerulenin.
    Omura S; Kitao C; Miyazawa J; Imai H; Takeshima H
    J Antibiot (Tokyo); 1978 Mar; 31(3):254-6. PubMed ID: 649519
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibition of the biosynthesis of leucomycin, a macrolide antibiotic, by cerulenin.
    Takeshima H; Kitao C; Omura S
    J Biochem; 1977 Apr; 81(4):1127-32. PubMed ID: 881413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioconversion and biosynthesis of 16-membered macrolide antibiotics. XV. Final steps in the biosynthesis of leucomycins.
    Kitao C; Hamada H; Ikeda H; Omura S
    J Antibiot (Tokyo); 1979 Oct; 32(10):1055-7. PubMed ID: 528366
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioconversion and biosynthesis of nanaomycins using cerulenin, a specific inhibitor of fatty acid and polyketide biosyntheses.
    Kitao C; Tanaka H; Minami S; Omura S
    J Antibiot (Tokyo); 1980 Jul; 33(7):711-6. PubMed ID: 7410214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid biosynthesis of derivatives of protylonolide and M-4365 by macrolide-producing microorganisms.
    Sadakane N; Tanaka Y; Omura S
    J Antibiot (Tokyo); 1982 Jun; 35(6):680-7. PubMed ID: 7118724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of candicidin biosynthesis by the lipogenic inhibitor cerulenin.
    Martin JF; Mcdaniel LE
    Biochim Biophys Acta; 1975 Dec; 411(2):186-94. PubMed ID: 811262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acylation specificity of midecamycin 3-O-acyltransferase within Streptomyces spiramyceticus F21].
    Ma C; Wu L; Dai J; Zhou H; Li J; Sun X; Zhang K; Xia H; Wang Y
    Sheng Wu Gong Cheng Xue Bao; 2008 Dec; 24(12):2086-92. PubMed ID: 19306580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of fattiviracin FV-8, an antiviral agent.
    Habib ES; Yokomizo K; Suzuki K; Uyeda M
    Biosci Biotechnol Biochem; 2001 Apr; 65(4):861-4. PubMed ID: 11388465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of two regulatory genes involved in carbomycin biosynthesis in Streptomyces thermotolerans.
    Zhong J; Lu Z; Dai J; He W
    Arch Microbiol; 2017 Sep; 199(7):1023-1033. PubMed ID: 28389815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the biosynthesis of 16-membered macrolide antibiotics using carbon-13 nuclear magnetic resonance spectroscopy.
    Omura S; Takeshima H; Nakagawa A; Miyazawa J; Piriou F; Lukacs G
    Biochemistry; 1977 Jun; 16(13):2860-6. PubMed ID: 18162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and biochemical features of spiramycin biosynthesis in Streptomyces ambofaciens--curing, protoplast regeneration and plasmid transfer.
    Ikeda H; Tanaka H; Omura S
    J Antibiot (Tokyo); 1982 Apr; 35(4):507-16. PubMed ID: 7096204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Biosynthetic studies using 13C enriched precursors on the 16-membered macrolide antibiotic leucomycin A3.
    Omura S; Nakagawa A; Takeshima H; Atusmi K; Miyazawa J; Piriou F; Lukacs G
    J Am Chem Soc; 1975 Oct; 97(22):6600-2. PubMed ID: 1184876
    [No Abstract]   [Full Text] [Related]  

  • 15. Hybrid biosynthesis of a new macrolide antibiotic by a daunomycin-producing microorganism.
    Sadakane N; Tanaka Y; Omura S
    J Antibiot (Tokyo); 1983 Jul; 36(7):921-2. PubMed ID: 6885644
    [No Abstract]   [Full Text] [Related]  

  • 16. Chimeramycins: new macrolide antibiotics produced by hybrid biosynthesis.
    Omura S; Sadakane N; Tanaka Y; Matsubara H
    J Antibiot (Tokyo); 1983 Jul; 36(7):927-30. PubMed ID: 6860432
    [No Abstract]   [Full Text] [Related]  

  • 17. The detection of a plasmid in Streptomyces ambofaciens KA-1028 and its possible involvement in spiramycin production.
    Omura S; Ikeda H; Kitao C
    J Antibiot (Tokyo); 1979 Oct; 32(10):1058-60. PubMed ID: 528367
    [No Abstract]   [Full Text] [Related]  

  • 18. New macrolide antibiotics produced by mutants from Streptomyces fradiae NRRL 2702.
    Okamoto R; Kiyoshima K; Yamamoto M; Takada K; Ohnuki T; Ishikura T; Naganawa H; Tatsuta K; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1982 Jul; 35(7):921-4. PubMed ID: 7174542
    [No Abstract]   [Full Text] [Related]  

  • 19. Spiramycin, a macrolide antibiotic.
    Abou-Zeid AZ; Khalil A el-G ; Rabei M
    Zentralbl Bakteriol Naturwiss; 1980; 135(5):443-53. PubMed ID: 6779436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The characterization of mutant No. 68 from midecamycin producing strain S. mycarofaciens 1748].
    Wang Y; Xiao C; Gong L; Liu R
    Wei Sheng Wu Xue Bao; 1992 Apr; 32(2):148-50. PubMed ID: 1598759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.